Pertussis (whooping cough) vaccine safety data

AusVaxSafety completed pertussis (whooping cough) booster vaccine safety active surveillance this month after nearly three years of monthly active surveillance. No safety signal was identified in children receiving DTPa at 18 months or DTPa-IPV at 4 years, with data contributed by over 55,000 participating parents/carers. Vaccine safety results are available on the AusVaxSafety website.

Injection site reactions are known to occur following administration of acellular pertussis vaccines. The current reported event rates are consistent with existing data on pertussis vaccines.

Influenza vaccine safety data 

Surveillance of 2019 influenza vaccine safety commenced from 1 April 2019. The current reported event rates are consistent with existing data on influenza vaccines.

 

AusVaxSafety surveillance tool

sv

Last updated May 2019